DMD gene guide: dystrophin, exon changes and reading-frame interpretation
Read a DMD genetic report accurately: deletions, duplications, sequence changes, reading-frame predictions, RNA evidence and treatment research questions.
Browse published, medically reviewed explanations. Search a gene, condition or research question, or narrow the collection by topic.
65 articles
Read a DMD genetic report accurately: deletions, duplications, sequence changes, reading-frame predictions, RNA evidence and treatment research questions.
Read a COL3A1 report with the exact variant, laboratory evidence and clinical context; understand type III collagen and limits of individual risk prediction.
A clear NF1 guide explaining skin findings, diagnostic assessment, age-related features, monitoring, family implications and questions for specialist care.
Understand an NF1 genetic finding: neurofibromin biology, inherited versus tumor context, mosaicism, testing limits and a practical evidence worksheet.
Understand autosomal dominant polycystic kidney disease: kidney cysts, imaging and genetic tests, blood pressure, family assessment and research outcomes.
Interpret PKD1 and PKD2 results with attention to exact variants, pseudogenes, assay coverage, family findings and the limits of individual prognosis.
Understand PKU and PAH deficiency, newborn-screen follow-up, phenylalanine monitoring, family genetics and pregnancy planning.
Understand inherited and acquired long QT syndrome, ECG interpretation, genetic results, family screening and questions for a cardiac genetics visit.
Read KCNQ1, KCNH2 and SCN5A results in context: ion channels, disease mechanisms, variant evidence, family testing and research limitations.
A practical Rett syndrome guide for families and researchers: developmental regression, clinical diagnosis, MECP2 testing, communication and care planning.
Understand FAP and attenuated FAP, APC testing, colorectal cancer prevention, ongoing follow-up and practical questions for a hereditary cancer clinic.
Read GBA1 results in context: Gaucher disease, gene-copy phase, pseudogene interference, enzyme evidence and the difference between Parkinson risk and diagnosis.